MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 12.03.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
9.4 M |
Marktkapitalisierung |
$ 528 M |
EBITDA (LTM) |
$ -90.2 M |
P/E (LTM) |
- |
P/S (LTM) |
36.39 |
EPS (LTM) |
-9.41 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AbCellera Biologics
ABCL
|
$ 3.54 | -0.56 % | $ 1.06 B | Nasdaq Global Select Market |  Canada |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 3.2 | 2.24 % | $ 229 M | Nasdaq Global Market |  Schweiz |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 4.17 | -1.18 % | $ 105 M | NYSE | Schweiz |
 |
Aptorum Group Limited
APM
|
$ 0.8 | 1.81 % | $ 4.36 M | Nasdaq Global Select Market | China |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 6.55 | -1.21 % | $ 179 M | Nasdaq Global Market,SPB |  Israel |
 |
argenx SE
ARGX
|
$ 710.47 | 1.02 % | $ 25 B | Nasdaq Global Select Market |  Niderland |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.41 | -5.54 % | $ 8.2 B | Nasdaq Capital Market |  Australia |
 |
Ascendis Pharma A/S
ASND
|
$ 229.89 | -0.49 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 1.28 | 0.55 % | $ 27.1 M | Nasdaq Global Select Market | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 6.12 | 1.16 % | $ 499 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.51 | -2.23 % | $ 7.64 B | NYSE American | Israel |
 |
Catalyst Biosciences
CBIO
|
$ 11.32 | -2.25 % | $ 1.01 B | Nasdaq Capital Market | USA |
 |
Anika Therapeutics
ANIK
|
$ 14.64 | 1.92 % | $ 215 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
CNS Pharmaceuticals
CNSP
|
$ 2.28 | -6.94 % | $ 872 K | Nasdaq Capital Market | USA |
 |
Aytu BioScience
AYTU
|
$ 2.64 | - | $ 16.6 M | Nasdaq Capital Market | USA |
 |
Curis
CRIS
|
$ 0.88 | 2.58 % | $ 5.55 M | Nasdaq Global Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.51 | - | $ 385 M | Nasdaq Global Select Market | Britain |
 |
BioNTech SE
BNTX
|
$ 92.24 | 1.88 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |